Document is current
Any future updates will be listed below
-
Authors
Jia, Dongsheng
Liu, Huan
Zhang, Jian
Wan, Wenqiang
Wang, Zongwen
Zhang, Xiaofeng
Chen, Qian
Wei, Taiyun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (31920103014)
National Natural Science Foundation of China (31970160)
Natural Science Foundation of Shanghai (31871931)
Natural Science Foundation of Fujian Province (2020J06015)
- License Information
-
More Information
Article History
Received: 23 October 2021
Accepted: 30 December 2021
First Online: 15 April 2022
Declarations
:
: The antibodies OAZ1 and ODC1 were produced by Genscript USA Innovation Company (Nanjing), which is approved by the Science Technology Department of Jiangsu Province, China with approval number SYXK (Su) 2018–0015.
: Not applicable.
: The authors declare no competing interests.
